Dr. Raveen Chawla, MD

Dr. Chawla practices at Winchester Medical Center in Winchester, Virginia, part of Valley Health.

Dr. Chawla's NPI, 1003235227, was assigned on April 15, 2014. Dr. Chawla graduated from Virginia Commonwealth University, School of Medicine in 2014. Dr. Chawla holds Virginia license 0101275370.

Dr. Chawla's primary practice is Winchester Medical Center, at 1840 Amherst St, Winchester, VA 22601 in Winchester City. The practice phone is (540) 536-8000.

Dr. Chawla's primary practice is Winchester Medical Center in Winchester, Virginia, part of Valley Health. Dr. Chawla is also affiliated with Shenandoah Memorial Hospital. The medical group on file is Valley Health. Dmand AI also links Dr. Chawla to 3 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chawla practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Chawla's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Chawla is board certified in advanced heart failure and transplant cardiology by the American Board of Internal Medicine. Dr. Chawla is licensed in Virginia.

CMS data shows 1,562 Medicare services from Dr. Chawla across 23 procedure codes in 2024, for 696 Medicare patients. Medicare paid $136,282 for them.

CMS counts 696 Medicare patients who saw Dr. Chawla in 2024. The largest group is 65 to 74, with 284 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chawla's median patient age at 73, with 43% women.

In 2024, Dr. Chawla wrote 2,627 Medicare Part D claims for 452 patients. 80% of them were for generic drugs. CMS names the drug for 2,453 of them, across 30 drugs with 11 or more claims each, at $508,494 in total drug cost. In 2023, CMS named 1,307 claims across 23 drugs.

Dr. Chawla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chawla as offering telehealth. CMS counts 55 procedures of coronary angioplasty and stenting by Dr. Chawla, more than 86% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Chawla, published from 2015 to 2022. 2016 was the busiest year, with 2. The most frequent topics are Cardiotonic Agents, Contrast Media and Coronary Angiography. Dr. Chawla has published most often in Int J Cardiol. Dr. Chawla's most frequent co-authors are Ion S. Jovin, MD, Antonio Abbate, MD and Jeremy S. Turlington, MD.

CMS Open Payments shows 243 general payments to Dr. Chawla from 28 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 62% of the total. Biotronik Inc. paid the most, $11,577.

Dr. Chawla graduated from Virginia Commonwealth University, School of Medicine in 2014.